EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Contraceptive uptake and compliance after structured contraceptive counseling ‐ secondary outcomes of the LOWE trial

Isabella Bizjak iD, Niklas Envall iD, Karin Emtell Iwarsson iD, Helena Kopp Kallner iD, Kristina Gemzell-Danielsson iD

Acta Obstetricia et Gynecologica Scandinavica · 2024

DOI: 10.1111/aogs.14792 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Acta Obstetricia et Gynecologica Scandinavica, 2024. Verfasst von Isabella Bizjak und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Contraceptive Agents, Long-Acting Reversible Contraception. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Vetenskapsrådet, Region Stockholm, Forskningsrådet om Hälsa, Arbetsliv och Välfärd.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Highly effective long‐acting reversible contraceptive (LARC) methods reduce unintended pregnancy rates; however, these methods are underutilized. The LOWE trial intervention provided structured contraceptive counseling resulting in increased uptake of LARC. This longitudinal follow up of the LOWE study assessed the long‐term impact of the intervention by investigating the contraceptive use at 12 months with a focus on continued use of LARC. Material and methods In the cluster randomized LOWE trial, abortion, youth, and maternal health clinics were randomized to provide either structured contraceptive counseling (intervention) or standard contraceptive counseling (control). The intervention consisted of an educational video on contraceptive methods, key questions asked by the health care provider, a tiered effectiveness chart and a box of contraceptive models. Women ≥ age 18, who were sexually active or planned to be in the upcoming 6 months, could participate in the study. We assessed self‐reported contraceptive use at three, six and 12 months. Contraceptive choice and switches were analyzed with descriptive statistics. Contraceptive use at 12 months and continued use of LARC were analyzed using mixed logistic regressions, with clinic included as a random effect. Analysis with imputed values were performed for missing data to test the robustness of results.

Results

Overall, at 12 months, women in the intervention group were more likely to be using a LARC method (aOR 1.90, 95% CI: 1.31–2.76) and less likely to be using a short‐acting reversible contraceptive (SARC) method (aOR 0.66, 95% CI: 0.46–0.93) compared to the control group. Women counseled at abortion (aOR 2.97, 95% CI: 1.36–6.75) and youth clinics (aOR 1.81, 95% CI: 1.08–3.03) were more likely to be using a LARC method, while no significant difference was seen in maternal health clinics (aOR 1.84, 95% CI: 0.96–3.66). Among women initiating LARC, continuation rates at 12 months did not differ between study groups (63.9% vs. 63.7%). The most common reasons for contraceptive discontinuation were wish for pregnancy, followed by irregular bleeding, and mood changes.

Conclusions

The LOWE trial intervention resulted in increased LARC use also at 12 months. Strategies on how to sustain LARC use needs to be further investigated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Contraceptive AgentsLong-Acting Reversible ContraceptionAdolescentFemaleHumansPregnancyContraceptionCounselingPregnancy RateAdult

Stichwörter der Autor:innen

LARCchoicecontinuationcontraceptioncontraceptive‐counselinglong‐acting reversible contraceptionunintended pregnancy

Substanzen

Contraceptive Agents

Autor:innen und Institutionen

  • Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
  • Division of Gynecology and Reproductive Medicine, Karolinska University Hospital, Stockholm, Sweden.
  • Department of Clinical Sciences at Danderyd Hospital, Division of Obstetrics and Gynecology, Karolinska Institutet, Stockholm, Sweden.
  • School of Health and Welfare, Dalarna University, Falun, Sweden.
  • Division of Obstetrics and Gynecology, Danderyd Hospital, Stockholm, Sweden.

ORCID-Profile: Isabella Bizjak, Niklas Envall, Karin Emtell Iwarsson, Helena Kopp Kallner, Kristina Gemzell-Danielsson

Förderung

  • Vetenskapsrådet
  • Region Stockholm
  • Forskningsrådet om Hälsa, Arbetsliv och Välfärd

Zitieren

APA

Bizjak, I., Envall, N., Emtell Iwarsson, K., Kopp Kallner, H., & Gemzell-Danielsson, K. (2024). Contraceptive uptake and compliance after structured contraceptive counseling ‐ secondary outcomes of the LOWE trial. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1111/aogs.14792

Vancouver

Bizjak I, Envall N, Emtell Iwarsson K, Kopp Kallner H, Gemzell-Danielsson K. Contraceptive uptake and compliance after structured contraceptive counseling ‐ secondary outcomes of the LOWE trial. Acta Obstetricia et Gynecologica Scandinavica. 2024. doi:10.1111/aogs.14792

BibTeX
@article{Bizjak2024,
  author = {Bizjak, Isabella and Envall, Niklas and Emtell Iwarsson, Karin and Kopp Kallner, Helena and Gemzell-Danielsson, Kristina},
  title = {Contraceptive uptake and compliance after structured contraceptive counseling ‐ secondary outcomes of the LOWE trial},
  journal = {Acta Obstetricia et Gynecologica Scandinavica},
  year = {2024},
  doi = {10.1111/aogs.14792}
}
Kostenlos starten →